Harvard
FDA Grants Emergency Use Authorizations for SARS-CoV-2 Tests From Harvard, NowDiagnostics
Harvard's RT-PCR-based test can be used with self-collected nasal samples, while NowDiagnostics' immunoassay can be used with fingerstick blood samples.
The group's printable biosensor plugs into a computer or smartphone and uses receptor ACE2 as well saliva or a nasal swab to detect SARS-CoV-2.
GBS Developing Organic Thin-Film Transistor Tech to Detect SARS-CoV-2 Antibodies, Monitor Glucose
Premium
GBS said it expects that later this year it will launch a multiplex assay, which it is developing with the Wyss Institute, to detect antibodies against SARS-CoV-2.
Harvard Licenses Nasal Swab Collection Tech to Rhinostics
The technology was developed for use in SARS-CoV-2 and other infectious disease testing by Rhinostics' cofounders at Harvard's Wyss Institute.
SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches
A pair of studies published this week present an analysis of a real, large-scale testing pooling effort as well as analyses of how to further improve such strategies.